Stock listing
MPLT Stock Price, News, Filings & Events — Maplight Therapeutics, Inc.
Selected listing: MPLT · BOATS · USD · US
This page tracks Maplight Therapeutics, Inc.'s MPLT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MPLT:BOATS. MPLT:BOATS is the stock-level entry point for investors researching Maplight Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maplight Therapeutics, Inc. (ticker: MPLT) is a public company based in the United States with a market capitalization of approximately $1.61 billion. The company focuses on developing innovative therapies aimed at improving patient outcomes. As a publicly traded entity, Maplight Therapeutics is positioned within the healthcare sector, contributing to advancements in medical treatments.

- Ticker
- MPLT:BOATS
- Asset type
- Stock
- Market cap
- $687.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Maplight Therapeutics, Inc. MPLT:BOATS stock context
This page tracks Maplight Therapeutics, Inc.'s MPLT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MPLT:BOATS. MPLT:BOATS is the stock-level entry point for investors researching Maplight Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maplight Therapeutics, Inc. (ticker: MPLT) is a public company based in the United States with a market capitalization of approximately $1.61 billion. The company focuses on developing innovative therapies aimed at improving patient outcomes. As a publicly traded entity, Maplight Therapeutics is positioned within the healthcare sector, contributing to advancements in medical treatments.
Latest news from Maplight Therapeutics, Inc.
MapLight Therapeutics to Participate in Upcoming Investor Conference
September 9, 2026
MapLight Therapeutics Announces $150 Million Private Placement Financing
August 13, 2026
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
July 27, 2026
MapLight Therapeutics Announces Changes to Board of Directors
June 24, 2026
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
June 22, 2026
Research Maplight Therapeutics, Inc.
Maplight Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for MPLT:BOATS.
Maplight Therapeutics, Inc. company profile
View the public company page for Maplight Therapeutics, Inc. on 6ix.
Maplight Therapeutics, Inc. news
Read company news and market updates connected to Maplight Therapeutics, Inc..
Maplight Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Maplight Therapeutics, Inc..